Targeting AFib-Related Stroke Patients with Reveal for Stroke

Learn how you can use Reveal for Stroke to take 100,000 screening ECGs and identify nearly 230 higher-risk AFib-related stroke patients.

Reduce AFib-related stroke risk

Reveal for Stroke closely examines ECGs to detect atrial fibrillation (AFib) or atrial flutter, conditions that often go unnoticed in routine health check-ups. Imagine sifting through ECGs from a hundred thousand patients – statistically, over 2,100 of them will show signs of AFib or flutter, yet around 20% of these cases are left undiagnosed in health records, leaving these individuals vulnerable to stroke.

Reveal analyzes existing patient records alongside their ECG data and automatically calculates the CHAD2S2-VASc score – a key measure of stroke risk. Reveal for Stroke can identify approximately 230 high-risk patients who require priority follow-up.

The benefits of early intervention are immeasurable. By managing these at-risk patients in an outpatient setting, Reveal for Stroke can reduce their chances of having a stroke by up to 70%. This not only saves lives, but it also significantly cuts healthcare costs. For a typical population, implementing Reveal for Stroke can prevent around 7 strokes and generate over $1.6 million in new outpatient revenue. This goes to show the dual advantage of Reveal for Stroke: enhancing patient care while also improving healthcare efficiency.

So why is this crucial for healthcare providers and patients alike? Because Reveal for Stroke not only fills a critical gap in patient care but also sets a new standard in proactive stroke risk management. By incorporating Reveal for Stroke into their healthcare practices, providers can offer high-value care that is both effective and efficient.

Get A Demo